Skip to main content

Table 1 Demographic and preoperative clinical data of the patients

From: Ultrasound-guided percutaneous insertion of small vascular surgical clips versus dedicated breast mammoclips as markers for breast cancer prior to neo-adjuvant therapy: a prospective randomized controlled trial

 

Group I (Surgical clips) (n = 80)

Group II (Commercial clips) (n = 80)

P value

Age n (%)

 < 40 years

39 (50.6%)

38 (49.9%)

0.293

 40–50 years

27 (44.3%)

34(55.7%)

 > 50 years

14 (63.6%)

8(36.4%)

BMI n (%)

 Normal

8 (80.0%)

2 (20.0%)

0.138

 Overweight

23 (46.0%)

27 (54.0%)

 Obese

49 (49.0%)

51 (51.0%)

Tumor size n (%)

 < 40 mm

11 (44.0%)

14 (56.0%)

0.715

 40–49 mm

23 (56.1%)

18 (43.9%)

 50–59 mm

26 (46.6%)

30 (53.6%)

 > 59 mm

20 (52.6%)

18 (47.4%)

Tumor site n (%)

 Central

12 (54.6%)

10 (45.4%)

0.882

 Lower Inner Quadrant

6 (42.9%)

8 (57.1%)

 Lower Outer Quadrant

7 (58.3%)

5 (41.7%)

 Upper Inner Quadrant

11 (55.0%)

9 (45.0%)

 Upper Outer Quadrant

44 (47.8%)

48 (52.2%)

Clinical staging n (%)

 IIA

10 (41.7%)

14 (58.3%)

0.701

 IIB

16 (45.7%)

19 (54.3%)

 IIIA

27 (54.0%)

23 (46.0%)

 IIIB

27 (52.9%)

24 (47.1%)

Histopathological type n (%)

 Infiltrative ductal carcinoma

64 (49.6%)

65 (50.4%)

0.841

 Infiltrative Lobular carcinoma

16 (51.6%)

15 (48.4%)

Molecular Subtype n (%)

 HER-2 Positive

25 (51.0%)

24 (49.0%)

0.980

 Luminal-A

20 (47.7%)

22 (52.3%)

 Luminal-B

8 (53.3%)

7(46.7%)

 Triple Negative

27 (50.0%)

27 (50.0%)

ARC Classification n (%)

 A

17 (51.5%)

16 (48.5%)

0.550

 B

25 (51.0%)

24 (49.0%)

 C

34 (52.3%)

31 (47.7%)

 D

4 (30.8%)

9 (69.2%)